Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities

This publication has 227 references indexed in Scilit:

• PARG dysfunction enhances DNA double strand break formation in S-phase after alkylation DNA damage and augments different cell death pathways
  Cell Death & Disease, 2013
• Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
  Cell Death & Disease, 2012
• Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
  Cell, 2012
• Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survival
  IUBMB Life, 2012
• In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
  Cancer Cell, 2010
• The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
  Molecular Cell, 2010
• Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
  Molecular Therapy, 2010
• Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase
  Cancer Chemotherapy and Pharmacology, 2010
• Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
  Cancer Immunology, Immunotherapy, 2008
• Molecular genetics of pancreatic intraepithelial neoplasia
  Journal of Hepato-Biliary-Pancreatic Surgery, 2007